Save time and get answers to complex questions with AI chat
How much is mebendazole?Are there specific stretches to avoid while on lipitor?Combivent inhaler hfc 152a patents?Zemdri plazomicin gain exclusivity 2028 patent 2031?Dabrafenib patent expiration date novartis gsk composition matter?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab), an immunotherapy for cancers like melanoma and lung cancer, can trigger immune-related adverse reactions where the immune system attacks healthy tissues. These often need immediate medical care to prevent severe outcomes like organ damage. Always contact your doctor or seek emergency help for new or worsening symptoms during treatment.[1]
Other Questions About Keytruda :